Eurofins Scientific SE Stock OTC Markets
Stocks
ERRFY
US29873U1060
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 13.27B 15.22B 12.53B 11.38B 21.32B 1,460B 21.41B 150B 57.92B 742B 57.17B 55.9B 2,389B | P/E 2026 * |
25.5x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 16.64B 19.08B 15.71B 14.26B 26.73B 1,831B 26.84B 188B 72.61B 931B 71.67B 70.07B 2,995B | EV / Sales 2026 * |
2.19x | EV / Sales 2027 * | 2.04x |
| Free-Float |
60.39% | Yield 2026 * |
1.05% | Yield 2027 * | 1.19% |
Last Transcript: Eurofins Scientific SE
| 10 years | 0 | 30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 15.22B | ||
| +0.11% | +2.71% | +0.33% | +28.59% | 46.28B | ||
| -1.12% | +1.78% | +40.07% | +27.26% | 43.85B | ||
| -3.04% | -6.29% | +322.27% | +517.36% | 40.93B | ||
| -0.74% | +1.25% | +2.32% | +67.94% | 39.9B | ||
| -0.50% | +0.67% | +11.79% | +40.51% | 29.5B | ||
| -0.46% | +4.22% | +21.99% | +124.21% | 17.09B | ||
| -0.97% | -10.17% | - | - | 15.55B | ||
| -0.57% | +8.12% | +22.15% | +38.93% | 15.22B | ||
| -3.14% | +31.91% | -10.60% | - | 14.05B | ||
| Average | -0.89% | +3.76% | +51.29% | +120.69% | 29.15B | |
| Weighted average by Cap. | -0.96% | +1.87% | +64.69% | +130.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.58B 8.7B 7.16B 6.5B 12.18B 834B 12.23B 85.77B 33.1B 424B 32.67B 31.94B 1,365B | 8B 9.17B 7.55B 6.86B 12.85B 880B 12.9B 90.46B 34.91B 447B 34.45B 33.69B 1,440B |
| Net income | 531M 609M 501M 455M 853M 58.42B 856M 6B 2.32B 29.7B 2.29B 2.24B 95.57B | 660M 757M 623M 566M 1.06B 72.59B 1.06B 7.46B 2.88B 36.91B 2.84B 2.78B 119B |
| Net Debt | 3.37B 3.86B 3.18B 2.89B 5.41B 370B 5.43B 38.07B 14.69B 188B 14.5B 14.18B 606B | 3.03B 3.48B 2.86B 2.6B 4.87B 334B 4.89B 34.31B 13.24B 170B 13.07B 12.78B 546B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
- ERRFY Stock
Select your edition
All financial news and data tailored to specific country editions


















